APO RESEARCH · REPORT
Arginine (Cas 74-79-3)
Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Product & engineering
Understand the product.
Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Selected research
Industry Growth & Trends
Global Arginine (Cas 74-79-3) Industry Growth and Trends Forecast to 2032
Market perspective
Arginine is a type of α-amino acid. The L-form is one of the 20 most common natural amino acids. A nonessential amino acid in human, Arginine is a substrate of nitric oxide synthase, which is converted to L-citrulline and nitric oxide (NO). It is widely used as an ingredient in dietary supplements, infusions and infant formulas.
Europe is the largest region of Arginine (Cas 74-79-3), with a market share about 30%. It was followed by North America with 25%. Ajinomoto group, KYOWA, Daesang, Jingjing, Jinghai Amino Acid and Jiahe Biotech are the leaders of of industry, and they had about 50% combined market share.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Arginine (Cas 74-79-3) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Arginine (Cas 74-79-3) market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Arginine (Cas 74-79-3) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Arginine (Cas 74-79-3).
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Arginine (Cas 74-79-3) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Arginine (Cas 74-79-3) Market by Company
Ajinomoto Group
KYOWA
Daesang
CJ
JingJing
Jinghai Amino Acid
Jiahe Biotech
SHINE STAR
Xingyu Technology
Longteng Biotech
Arginine (Cas 74-79-3) Segment by Type
Food Grade
Pharma Grade
Others
Arginine (Cas 74-79-3) Segment by Application
Supplements & Nutrition
Pharmaceuticals
Cosmetics
Others
Arginine (Cas 74-79-3) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arginine (Cas 74-79-3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arginine (Cas 74-79-3) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arginine (Cas 74-79-3).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arginine (Cas 74-79-3) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Arginine (Cas 74-79-3) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Pharma Grade
- Others
Applications
- Supplements & Nutrition
- Pharmaceuticals
- Cosmetics
- Others
Companies covered
- Ajinomoto Group
- KYOWA
- Daesang
- CJ
- JingJing
- Jinghai Amino Acid
- Jiahe Biotech
- SHINE STAR
- Xingyu Technology
- Longteng Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Arginine (Cas 74-79-3) Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Arginine (Cas 74-79-3) Sales Estimates and Forecasts (2021-2032)
- 1.3 Arginine (Cas 74-79-3) Market by Type
- 1.3.1 Food Grade
- 1.3.2 Pharma Grade
- 1.3.3 Others
- 1.4 Global Arginine (Cas 74-79-3) Market Size by Type
- 1.4.1 Global Arginine (Cas 74-79-3) Market Size Overview by Type (2021-2032)
- 1.4.2 Global Arginine (Cas 74-79-3) Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Arginine (Cas 74-79-3) Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Arginine (Cas 74-79-3) Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Arginine (Cas 74-79-3) Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Arginine (Cas 74-79-3) Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Arginine (Cas 74-79-3) Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Arginine (Cas 74-79-3) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Arginine (Cas 74-79-3) Industry Trends
- 2.2 Arginine (Cas 74-79-3) Industry Drivers
- 2.3 Arginine (Cas 74-79-3) Industry Opportunities and Challenges
- 2.4 Arginine (Cas 74-79-3) Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Arginine (Cas 74-79-3) Revenue (2021-2026)
- 3.2 Global Top Players by Arginine (Cas 74-79-3) Sales (2021-2026)
- 3.3 Global Top Players by Arginine (Cas 74-79-3) Price (2021-2026)
- 3.4 Global Arginine (Cas 74-79-3) Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Arginine (Cas 74-79-3) Major Company Production Sites & Headquarters
- 3.6 Global Arginine (Cas 74-79-3) Company, Product Type & Application
- 3.7 Global Arginine (Cas 74-79-3) Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Arginine (Cas 74-79-3) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Arginine (Cas 74-79-3) Players Market Share by Revenue in 2025
- 3.8.3 2025 Arginine (Cas 74-79-3) Tier 1, Tier 2, and Tier 3
4 Arginine (Cas 74-79-3) Regional Status and Outlook
- 4.1 Global Arginine (Cas 74-79-3) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Arginine (Cas 74-79-3) Historic Market Size by Region
- 4.2.1 Global Arginine (Cas 74-79-3) Sales in Volume by Region (2021-2026)
- 4.2.2 Global Arginine (Cas 74-79-3) Sales in Value by Region (2021-2026)
- 4.2.3 Global Arginine (Cas 74-79-3) Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Arginine (Cas 74-79-3) Forecasted Market Size by Region
- 4.3.1 Global Arginine (Cas 74-79-3) Sales in Volume by Region (2027-2032)
- 4.3.2 Global Arginine (Cas 74-79-3) Sales in Value by Region (2027-2032)
- 4.3.3 Global Arginine (Cas 74-79-3) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Arginine (Cas 74-79-3) by Application
- 5.1 Arginine (Cas 74-79-3) Market by Application
- 5.1.1 Supplements & Nutrition
- 5.1.2 Pharmaceuticals
- 5.1.3 Cosmetics
- 5.1.4 Others
- 5.2 Global Arginine (Cas 74-79-3) Market Size by Application
- 5.2.1 Global Arginine (Cas 74-79-3) Market Size Overview by Application (2021-2032)
- 5.2.2 Global Arginine (Cas 74-79-3) Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Arginine (Cas 74-79-3) Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Arginine (Cas 74-79-3) Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Arginine (Cas 74-79-3) Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Arginine (Cas 74-79-3) Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Arginine (Cas 74-79-3) Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Arginine (Cas 74-79-3) Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Ajinomoto Group
- 6.1.1 Ajinomoto Group Company Information
- 6.1.2 Ajinomoto Group Business Overview
- 6.1.3 Ajinomoto Group Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Ajinomoto Group Arginine (Cas 74-79-3) Product Portfolio
- 6.1.5 Ajinomoto Group Recent Developments
- 6.2 KYOWA
- 6.2.1 KYOWA Company Information
- 6.2.2 KYOWA Business Overview
- 6.2.3 KYOWA Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 KYOWA Arginine (Cas 74-79-3) Product Portfolio
- 6.2.5 KYOWA Recent Developments
- 6.3 Daesang
- 6.3.1 Daesang Company Information
- 6.3.2 Daesang Business Overview
- 6.3.3 Daesang Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Daesang Arginine (Cas 74-79-3) Product Portfolio
- 6.3.5 Daesang Recent Developments
- 6.4 CJ
- 6.4.1 CJ Company Information
- 6.4.2 CJ Business Overview
- 6.4.3 CJ Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 CJ Arginine (Cas 74-79-3) Product Portfolio
- 6.4.5 CJ Recent Developments
- 6.5 JingJing
- 6.5.1 JingJing Company Information
- 6.5.2 JingJing Business Overview
- 6.5.3 JingJing Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 JingJing Arginine (Cas 74-79-3) Product Portfolio
- 6.5.5 JingJing Recent Developments
- 6.6 Jinghai Amino Acid
- 6.6.1 Jinghai Amino Acid Company Information
- 6.6.2 Jinghai Amino Acid Business Overview
- 6.6.3 Jinghai Amino Acid Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Jinghai Amino Acid Arginine (Cas 74-79-3) Product Portfolio
- 6.6.5 Jinghai Amino Acid Recent Developments
- 6.7 Jiahe Biotech
- 6.7.1 Jiahe Biotech Company Information
- 6.7.2 Jiahe Biotech Business Overview
- 6.7.3 Jiahe Biotech Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Jiahe Biotech Arginine (Cas 74-79-3) Product Portfolio
- 6.7.5 Jiahe Biotech Recent Developments
- 6.8 SHINE STAR
- 6.8.1 SHINE STAR Company Information
- 6.8.2 SHINE STAR Business Overview
- 6.8.3 SHINE STAR Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 SHINE STAR Arginine (Cas 74-79-3) Product Portfolio
- 6.8.5 SHINE STAR Recent Developments
- 6.9 Xingyu Technology
- 6.9.1 Xingyu Technology Company Information
- 6.9.2 Xingyu Technology Business Overview
- 6.9.3 Xingyu Technology Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Xingyu Technology Arginine (Cas 74-79-3) Product Portfolio
- 6.9.5 Xingyu Technology Recent Developments
- 6.10 Longteng Biotech
- 6.10.1 Longteng Biotech Company Information
- 6.10.2 Longteng Biotech Business Overview
- 6.10.3 Longteng Biotech Arginine (Cas 74-79-3) Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Longteng Biotech Arginine (Cas 74-79-3) Product Portfolio
- 6.10.5 Longteng Biotech Recent Developments
7 North America by Country
- 7.1 North America Arginine (Cas 74-79-3) Sales by Country
- 7.1.1 North America Arginine (Cas 74-79-3) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Arginine (Cas 74-79-3) Sales by Country (2021-2026)
- 7.1.3 North America Arginine (Cas 74-79-3) Sales Forecast by Country (2027-2032)
- 7.2 North America Arginine (Cas 74-79-3) Market Size by Country
- 7.2.1 North America Arginine (Cas 74-79-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Arginine (Cas 74-79-3) Market Size by Country (2021-2026)
- 7.2.3 North America Arginine (Cas 74-79-3) Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Arginine (Cas 74-79-3) Sales by Country
- 8.1.1 Europe Arginine (Cas 74-79-3) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Arginine (Cas 74-79-3) Sales by Country (2021-2026)
- 8.1.3 Europe Arginine (Cas 74-79-3) Sales Forecast by Country (2027-2032)
- 8.2 Europe Arginine (Cas 74-79-3) Market Size by Country
- 8.2.1 Europe Arginine (Cas 74-79-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Arginine (Cas 74-79-3) Market Size by Country (2021-2026)
- 8.2.3 Europe Arginine (Cas 74-79-3) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Arginine (Cas 74-79-3) Sales by Country
- 9.1.1 Asia-Pacific Arginine (Cas 74-79-3) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Arginine (Cas 74-79-3) Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Arginine (Cas 74-79-3) Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Arginine (Cas 74-79-3) Market Size by Country
- 9.2.1 Asia-Pacific Arginine (Cas 74-79-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Arginine (Cas 74-79-3) Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Arginine (Cas 74-79-3) Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Arginine (Cas 74-79-3) Sales by Country
- 10.1.1 South America Arginine (Cas 74-79-3) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Arginine (Cas 74-79-3) Sales by Country (2021-2026)
- 10.1.3 South America Arginine (Cas 74-79-3) Sales Forecast by Country (2027-2032)
- 10.2 South America Arginine (Cas 74-79-3) Market Size by Country
- 10.2.1 South America Arginine (Cas 74-79-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Arginine (Cas 74-79-3) Market Size by Country (2021-2026)
- 10.2.3 South America Arginine (Cas 74-79-3) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Arginine (Cas 74-79-3) Sales by Country
- 11.1.1 Middle East and Africa Arginine (Cas 74-79-3) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Arginine (Cas 74-79-3) Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Arginine (Cas 74-79-3) Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Arginine (Cas 74-79-3) Market Size by Country
- 11.2.1 Middle East and Africa Arginine (Cas 74-79-3) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Arginine (Cas 74-79-3) Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Arginine (Cas 74-79-3) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Arginine (Cas 74-79-3) Value Chain Analysis
- 12.1.1 Arginine (Cas 74-79-3) Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Arginine (Cas 74-79-3) Production Mode & Process
- 12.2 Arginine (Cas 74-79-3) Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Arginine (Cas 74-79-3) Distributors
- 12.2.3 Arginine (Cas 74-79-3) Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst